BOSTONBIOHealthcare Service Provider
Boston Bio Systems Ltd — Cash Flow Statement
₹8.29
-4.93%
Boston Bio Systems Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -4.58 Cr | 0.00 | -12000.00 | -18800.00 | — |
| Repayment Of Debt | 0.00 | 0.00 | — | — | — |
| Issuance Of Debt | 4.57 Cr | 0.00 | 0.00 | 0.00 | — |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | — |
| End Cash Position | 0.04 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Beginning Cash Position | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Changes In Cash | -98000.00 | 0.00 | -12000.00 | -18800.00 | — |
| Financing Cash Flow | 4.57 Cr | 0.00 | 0.00 | 0.00 | — |
| Common Stock Dividend Paid | 0.00 | 0.00 | 0.00 | — | — |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Issuance Payments Of Debt | 4.57 Cr | 0.00 | 0.00 | 0.00 | — |
| Net Long Term Debt Issuance | 4.57 Cr | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt Payments | 0.00 | 0.00 | — | — | — |
| Long Term Debt Issuance | 4.57 Cr | 0.00 | 0.00 | 0.00 | — |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Interest Received Cfi | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE Purchase And Sale | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Sale Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Purchase Of PPE | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Operating Cash Flow | -4.58 Cr | 0.00 | -12000.00 | -18800.00 | — |
| Taxes Refund Paid | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Change In Working Capital | -4.04 Cr | 0.14 Cr | 10000.00 | 0.00 | — |
| Change In Other Current Liabilities | 0.05 Cr | 0.14 Cr | 10000.00 | — | — |
| Change In Other Current Assets | -4.34 Cr | 0.00 | 0.00 | — | — |
| Change In Payable | 0.26 Cr | — | 10000.00 | — | 10000.00 |
| Change In Receivables | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Depreciation And Amortization | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income From Continuing Operations | -0.55 Cr | -0.14 Cr | -22000.00 | -18800.00 | — |
| Interest Paid Cff | — | 0.00 | 0.00 | — | — |
| Net Short Term Debt Issuance | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Short Term Debt Issuance | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase Of Investment | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Change In Inventory | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Cfo | — | — | 0.00 | 0.00 | 0.00 |
| Provisionand Write Offof Assets | — | — | 0.00 | 0.00 | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | — | 10000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Boston Bio Systems Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.